Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Jim Van Meerten

Up 460% in the Past Year, Should You Take a Gamble on This Speculative Stock?

  • Erasca (ERAS) has surged 460% over the past year, driven by strong technical momentum.
  • ERAS hit a new 3-year high of $10.92 on Monday.
  • Despite bullish technicals, ERAS has no revenue, is burning cash, and its future hinges on FDA drug approvals.
  • Analyst sentiment is highly speculative, with price targets ranging from $2 to $16.

Today’s Featured Stock

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.